COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 195 filers reported holding COHERUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $88,859 | -39.0% | 20,810 | -2.3% | 0.00% | -50.0% |
| Q1 2023 | $145,760 | -13.9% | 21,310 | -0.3% | 0.00% | 0.0% |
| Q4 2022 | $169,250 | -16.6% | 21,370 | +1.4% | 0.00% | -33.3% |
| Q3 2022 | $203,000 | +32.7% | 21,074 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $153,000 | -80.6% | 21,074 | -65.4% | 0.00% | -75.0% |
| Q1 2022 | $787,000 | -19.8% | 60,937 | -0.8% | 0.01% | -27.3% |
| Q4 2021 | $981,000 | -53.5% | 61,437 | -53.2% | 0.01% | -54.2% |
| Q3 2021 | $2,111,000 | +17.0% | 131,361 | +0.7% | 0.02% | +20.0% |
| Q2 2021 | $1,805,000 | -5.3% | 130,478 | 0.0% | 0.02% | -13.0% |
| Q1 2021 | $1,906,000 | -15.3% | 130,478 | +0.8% | 0.02% | -23.3% |
| Q4 2020 | $2,251,000 | -5.5% | 129,488 | -0.3% | 0.03% | -14.3% |
| Q3 2020 | $2,382,000 | +448.8% | 129,884 | +434.5% | 0.04% | +483.3% |
| Q2 2020 | $434,000 | – | 24,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |